[Form 4] HeartBeam, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Branislav Vajdic, listed as Chief Executive Officer and director of HeartBeam, Inc. (BEAT), reported changes in his beneficial ownership. The filing shows a disposition of 878,664 shares of common stock and reports beneficial ownership of 1,428,424 common shares following the reported transactions. The report also discloses derivative securities: options with a $1.65 exercise price tied to 54,424 underlying common shares and an indicated date of 07/01/2035. An explanatory note states options were granted on September 30, 2025 and vesting occurs in two tranches after a July 1, 2025 vesting commencement date. The form is signed by Mr. Vajdic on 10/02/2025.

Insights

Corporate Governance Expert

TL;DR: CEO reported a large share disposition but retains substantial holdings and equity awards.

The filing shows a reported disposition of 878,664 common shares while still holding 1,428,424 shares beneficially. Large insider sales alongside meaningful retained ownership can affect perceptions of alignment between management and shareholders.

The director/officer signature on 10/02/2025 confirms the change was timely disclosed under Section 16 rules.

Equity Compensation Expert

TL;DR: New option award details and vesting schedule are disclosed, clarifying future equity dilution timing.

The report discloses options with a $1.65 exercise price covering 54,424 shares and an expiration/notation of 07/01/2035. The explanatory note states the options were granted on September 30, 2025 and vest in two tranches after a July 1, 2025 vesting commencement date, which specifies when those shares may become exercisable.

These award terms are relevant for modeling potential dilution once vesting and exercise occur.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Vajdic Branislav

(Last) (First) (Middle)

2118 WALSH AVE, SUITE 210

(Street)

SANTA CLARA CA 95050

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
HeartBeam, Inc. [ BEAT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
07/11/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock								878,664	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Common Stock (right to buy)	$1.65							(1)	07/01/2035	Common Stock	54,424		1,428,424	D

Explanation of Responses:

1. Granted options on September 30, 2025, one half of the total number of Shares subject to the Special Option shall vest on the three-month anniversary of the vesting commencement date (July 1, 2025) and the remaining Shares shall vest on the six-month anniversary of the vesting commencement date. These options have been issued from the Company's 2022 Equity Incentive Plan.

Remarks:

	/s/ Branislav Vajdic	10/02/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did HeartBeam (BEAT) disclose by the CEO?

The CEO, Branislav Vajdic, reported a disposition of 878,664 common shares and beneficial ownership of 1,428,424 shares after the transaction.

Did the Form 4 disclose any option grants for BEAT insiders?

Yes. The form reports options with an exercise price of $1.65 covering 54,424 underlying common shares, with a referenced date of 07/01/2035 and grant date noted as September 30, 2025.

What is the vesting schedule disclosed for the granted options?

Per the explanation, one half of the total number of shares subject to the special option vests on the three-month anniversary of the vesting commencement date (July 1, 2025) and the remainder vests on the six-month anniversary.

When was the Form 4 signed by the reporting person?

The Form 4 bears the signature of Branislav Vajdic dated 10/02/2025.

What titles does the reporting person hold at HeartBeam?

The filing lists the reporting person as a Director and Officer with the officer title Chief Executive Officer.